open access

Vol 73, No 3-4 (2005)
ORIGINAL PAPERS
Published online: 2008-02-18
Submitted: 2013-02-22
Get Citation

FEV1 after 3 years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease

Renata Zagdańska, Iwona Grzelewska-Rzymowska
Pneumonol Alergol Pol 2005;73(3-4):142-147.

open access

Vol 73, No 3-4 (2005)
ORIGINAL PAPERS
Published online: 2008-02-18
Submitted: 2013-02-22

Abstract

Obstruction of airways is characteristic for both asthma and COPD. It can be measured with spirometric tests. The most important ventilatory parameter is forced expiratory volume in first second-FEV1.The aim of our study was to characterise patients with severe asthma and COPD by ventilatory parameters after 3 years of observations. We examined 49 patients with asthma and 23 patients with COPD. We found an incomplete reversibility of airflow obstruction in 20 asthmatic patients,further analyses was performed for two asthmatics' groups with complete(CRAO) and incomplete reversibility of airflow obstruction(IRAO). In patients with IRAO ventilatory parameters were: mean FEV1 - 1,8 l, FVC - 2,3 l, MEF 50 - 1,9 l/s, After 3 years FEV1 decreased 180 ml. In patients with CRAO mean ventilatory parameters were FEV1-1,6 l, FVC- 2,1 l, MEF 50 - 1,8 l/s. After 3 years FEV1 decreased by 70 ml. In COPD patients mean ventilatory parameters were FEV1-1,2 l, FVC - 1,9 l, MEF 50 - 1,2 l/s. After 3 years FEV1 decreased by 170 ml. Although in patients who did not smoke FEV1 decreased less than in current smokers. In non-smokers FEV1 decreased 130 ml and in smokers 200 ml. Thus in asthmatics with IRAO, the decrease of FEV1 was similar to one observed in smokers with COPD, so we concluded the long treatment with corticosteroids in some patients with asthma did not stoppe the progress of the disease. It is also possible that in some asthma patients changes in airways characteristic for asthma coexisted with that characteristic for COPD.
Pneumonol. Alergol. Pol. 2005, 73, 142-147.

Abstract

Obstruction of airways is characteristic for both asthma and COPD. It can be measured with spirometric tests. The most important ventilatory parameter is forced expiratory volume in first second-FEV1.The aim of our study was to characterise patients with severe asthma and COPD by ventilatory parameters after 3 years of observations. We examined 49 patients with asthma and 23 patients with COPD. We found an incomplete reversibility of airflow obstruction in 20 asthmatic patients,further analyses was performed for two asthmatics' groups with complete(CRAO) and incomplete reversibility of airflow obstruction(IRAO). In patients with IRAO ventilatory parameters were: mean FEV1 - 1,8 l, FVC - 2,3 l, MEF 50 - 1,9 l/s, After 3 years FEV1 decreased 180 ml. In patients with CRAO mean ventilatory parameters were FEV1-1,6 l, FVC- 2,1 l, MEF 50 - 1,8 l/s. After 3 years FEV1 decreased by 70 ml. In COPD patients mean ventilatory parameters were FEV1-1,2 l, FVC - 1,9 l, MEF 50 - 1,2 l/s. After 3 years FEV1 decreased by 170 ml. Although in patients who did not smoke FEV1 decreased less than in current smokers. In non-smokers FEV1 decreased 130 ml and in smokers 200 ml. Thus in asthmatics with IRAO, the decrease of FEV1 was similar to one observed in smokers with COPD, so we concluded the long treatment with corticosteroids in some patients with asthma did not stoppe the progress of the disease. It is also possible that in some asthma patients changes in airways characteristic for asthma coexisted with that characteristic for COPD.
Pneumonol. Alergol. Pol. 2005, 73, 142-147.
Get Citation

Keywords

bronchial asthma; COPD; ventilatory parameters; 3y follow-up

About this article
Title

FEV1 after 3 years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease

Journal

Advances in Respiratory Medicine

Issue

Vol 73, No 3-4 (2005)

Pages

142-147

Published online

2008-02-18

Bibliographic record

Pneumonol Alergol Pol 2005;73(3-4):142-147.

Keywords

bronchial asthma
COPD
ventilatory parameters
3y follow-up

Authors

Renata Zagdańska
Iwona Grzelewska-Rzymowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl